Home › Targets › HDAC

HDAC (2 companies · 3 programs)

Companies with an active program directed at HDAC.

Lexeo Therapeutics, Inc. LXEO

LX3010 — Friedreich Ataxia
LX3030 — Friedreich Ataxia Preclinical

Vanda Pharmaceuticals Inc. VNDA

VTR-297 — Onychomycosis Phase 1